Industrial Hemp in north america: production, politics and potential

This article is originally written by Jerome H. Cherny, School of Integrative Plant Science, Soil and Crop Sciences Section, Cornell University, Ithaca, NY 14853, USA
Ernest Small, 
Science and Technology Branch, Agriculture and Agri-Food Canada, Ottawa, ON K1A 0C6, Canada
Academic Editor: Peter Langridge


Most of the Western World banned the cultivation of Cannabis sativa in the early 20th century because biotypes high in ∆9-tetrahydrocannabinol (THC, the principal intoxicant cannabinoid) are the source of marijuana. Nevertheless, since 1990, dozens of countries have authorized the licensed growth and processing of “industrial hemp” (cultivars with quite low levels of THC). Canada has concentrated on hemp oilseed production, and very recently, Europe changed its emphasis from fiber to oilseed. The USA, historically a major hemp producer, appears on the verge of reintroducing industrial hemp production. This presentation provides updates on various agricultural, scientific, social, and political considerations that impact the commercial hemp industry in the United States and Canada. The most promising scenario for the hemp industry in North America is a continuing focus on oilseed production, as well as cannabidiol (CBD), the principal non-intoxicant cannabinoid considered by many to have substantial medical potential, and currently in great demand as a pharmaceutical. Future success of the industrial hemp industry in North America is heavily dependent on the breeding of more productive oilseed cultivars, the continued development of consumer goods, reasonable but not overly restrictive regulations, and discouragement of overproduction associated with unrealistic enthusiasm. Changing attitudes have generated an unprecedented demand for the cannabis plant and its products, resulting in urgent needs for new legislative, regulatory, and business frameworks, as well as scientific, technological, and agricultural research.


Cannabis sativa L. is usually the only species of Cannabis recognized (and so is often referred to simply as Cannabis in this paper). This species has an extremely long association with humans. It is believed to have been a “camp follower” [1] during the nomadic, pre-agriculture stages of human development, thriving near ancient encampments associated with open areas, well-manured soils, and nearby streams, conditions providing the ideal habitat for the plant. Cannabis is one of the most ancient domesticated crops, cultivated for millennia. In the temperate world, as “hemp”, it was cultivated virtually exclusively as a bast (stem) fiber source, and the biotypes grown were so low in ∆9-tetrahydrocannabinol (THC), the principal intoxicating constituent of cannabis plants, that they could not be used as inebriants [2]. By contrast, in southern Asia, C. sativa biotypes were selected that were very high in THC for use as spiritual and recreational drugs. Although only high-THC strains are employed for marijuana, concern over the growing use of the plant for drugs led to most of the Western World banning the cultivation of all forms of C. sativa in the early 20th century. By that time, competitive crops (cotton and other tropical fiber plants) had become much more important. Nevertheless, hemp production persisted in some countries, particularly China, where much of the world’s hemp for fiber is grown today.
Cannabis contains genetically different biotypes of both industrial (non-intoxicant) hemp and marijuana [2]. “Hemp” or “industrial hemp” will be used interchangeably hereafter to refer to non-intoxicating C. sativa. Industrial hemp is sometimes referred to as “true hemp” to distinguish it from numerous other unrelated plant species that include “hemp” in their common names. Classification of Cannabis as either marijuana or industrial hemp is typically based on a threshold concentration of THC. Although a level of 1% THC is considered a minimum value to elicit an intoxicating effect, current laws in Canada and several other jurisdictions use 0.3% THC as the arbitrary threshold point at which cannabinoid content is used to distinguish strains of hemp from marijuana (a criterion first established by Small and Cronquist [3]). Cultivars of hemp must have less than the threshold THC concentration to be grown under license in Western countries permitting hemp cultivation. The European Union originally used a threshold value of 0.8%, later reducing it to 0.3%, and subsequently lowered to 0.2% THC. The reduction of the EU THC threshold to 0.2% was ostensibly done in the interests of safety, although 0.3% is widely accepted as sufficient. Excessive reduction of the criterion, which favors recent French cultivars over other sources, has the undesirable effect of eliminating some useful cultivars (e.g., FINOLA).
While “Cannabis” refers to a taxonomic genus, non-italicized, “cannabis” is a generic abstraction, widely used as a noun and adjective, and commonly (often loosely) used both for cannabis plants and/or any or all of the intoxicant preparations made from them. Note that throughout this review we use the term “intoxicant” in the standard dictionary sense of “inebriant”, not implying toxicity as do related words such as “intoxication”. However, in its most comprehensive sense “cannabis” also includes non-intoxicant, “industrial” preparations, which could be non-psychoactive medicinal drugs or other useful chemicals, fiber products (such as textiles, plastics and dozens of construction materials) and edible seed products [2].
Seed from industrial hemp is commonly referred to as “hempseed”, and the oilseed industry typically refers to the fixed vegetable oil extracted from hempseed as “hempseed oil”. Hempseed oil is distinguished from aromatic essential oils distilled from hemp inflorescences and/or foliage, and from “hash oil”, an extremely concentrated intoxicating more or less tarry preparation from high-THC strains. Although commonly referred to as a “seed”, the fruiting body of hemp is an achene, i.e., a fruit containing a seed. Hulling (i.e., removing the hull) from a hemp achene effectively removes the pericarp, leaving the true seed.2. North American History in BriefHemp was cultivated in temperate Eurasia for millennia, and is believed to have been first brought to North America in 1606 [4]. It was grown mainly for fiber in European settlements in Canada and the USA for several hundred years. The industry thrived in Kentucky, Missouri, and Illinois between 1840 and 1860, but was confined to Kentucky from the end of the civil war until around 1912 [5]. In the 1920s, both Agriculture Canada and the US Department of Agriculture (USDA) were still conducting hemp fiber research. During World War I the hemp fiber industry briefly expanded to 12 USA states. There was also a small commercial hemp fiber industry in Canada in the 1920s and early 1930s, mostly in western provinces. In general during the 20th century hemp fiber became much less competitive for rope, apparel, and paper, and became obsolete for a variety of minor uses such as a waterproof packing [2].
In 1938, the Canadian Opium and Narcotics Act made cultivation of all Cannabisillegal. The US Marihuana Tax Act of 1938 did not technically make Cannabiscultivation illegal in the USA, but placed marijuana under control of the USA Treasury Department, requiring permission from the US Drug Enforcement Agency (USDEA) to grow Cannabis. A brief revival of hemp production in both Canada and the USA occurred during World War II, with 68,000 metric tons (MT) of hemp fiber produced on 59,000 hectares (ha) in the USA in 1943 (Figure 1) [6], but the 1938 legislation in both countries effectively eliminated hemp production in North America post World War II. One exception was the Rens Hemp Company of Wisconsin which was permitted by USDEA to produce hemp fiber until 1958 [4]. In 1970, the US Congress repealed the 1937 Marijuana Tax Act and replaced it with the Comprehensive Drug Abuse Prevention and Control Act. Although the 1970 Act did create a distinction between marijuana and hemp, USDEA policy following the Act treated marijuana and hemp as the same plant.

​Figure 1. Harvested area (ha) of hemp for fiber and for seed in the USA during the 1930’-s and 1940’-s. Source:
In 1994, Canada started issuing licenses to allow research on industrial hemp. In 1998, new regulations included in the Canadian Controlled Drugs and Substances Act permitted commercial cultivation of hemp, under licensing and control of Health Canada. Section 7606 of the US Agricultural Act of 2014 authorized state departments of agriculture to permit pilot programs for industrial hemp research, although hemp remains classified as a Schedule 1 controlled substance under the USA Controlled Substances Act. Permission from both state departments of agriculture and USDEA are required to evaluate hemp in the USA under strictly controlled conditions.
Cannabis readily escapes from cultivation and establishes as a ruderal plant. After being introduced to North America as a field crop, it gradually spread from the primary areas of cultivation. Today, wild or ruderal Cannabis can be found in most states [6] and provinces [7], but remains more concentrated in southern Ontario and southern Quebec, and in the Midwest and Northeast USA, where hemp cultivation was focused in recent centuries. There have been concentrated efforts by law enforcement to eradicate wild hemp in North America, although it is not an aggressive weed and has virtually no capacity to produce intoxication. However, plants apparently growing wild in parks and wilderness areas are often marijuana strains being illegally cultivated.

Potential Uses for Hemp in North America 

While there are as many as 50,000 uses claimed for hemp products [8], there are only a few hemp products with the potential to generate a significant market. Three major product categories with market potential are: (1) fiber; (2) oilseed; and (3) pharmaceuticals.
3.1. Fiber
Hemp fiber constitutes an outer ring of long phloem fibers (“bast” or “bark”) and an inner core of short xylem (“wood”) fibers, the former of much greater value than the latter [4]. The inner core of short, stiff, xylem fibers along with remnants of the stem pith are collectively called hemp hurds. The outer primary phloem fibers of the stem grow very long in amalgamated bundles, and are supplemented by secondary phloem tissue produced to the inside of the primary phloem and composed of much shorter fibers. Long bast fibers are valuable, short bast fibers are less valuable, and hurd fibers are about half the value of bast [9]. Separation of bast from hurds is called “retting”, with several methods for selectively removing pectic substances that bind the bast fibers to the less desirable parts of the stem. Bast fibers are preferred for automotive applications, and making specialty papers and textiles. Hurd fibers are primarily used for animal bedding and hemp–lime construction applications, and sometimes also for fiberboard [4].
The world hemp fiber market has been relatively stable the past 20 years [10] (Figure 2), even though EU hemp production was reinitiated during this period and fiber production peaked in the late 1990’-s [10] (Figure 3). The FAO data provided in Figure 3 appears to differ substantially from recent European Industrial Hemp Association [11] data for 2013, particularly for hempseed production. European hemp production initially focused on fiber, and the industry has been heavily subsidized by the EU. While synthetic fibers are derived from fossil fuels, natural fibers are extracted directly from plant and animal species, with cotton (Gossypium spp.) and wool as the primary examples, and flax (Linum usitatissiumum L.), sisal (Agave sisalina Perrine), jute (Corchorus sp.), kenaf (Hibiscus cannabinus L.), and abaca (Musa textilis L.) as examples of natural fibers with niche markets. Cotton accounts for about 85% of the natural fiber textile market worldwide, while hemp accounts for less than 0.5% [12]. Although hemp pulp is not as profitable as wood pulp, and hemp has more environmental concerns regarding water consumption, soil erosion, and soil nutrient depletion [13], a niche market in Europe has developed for hemp cigarette paper. High quality bast is used along with other natural fibers for a variety of fiber biocomposites for automobiles [14,15]. Hemp has about a 15% market share of the EU automobile biocomposite industry, while about 15% of the total hemp fiber produced in the EU is used for automobile biocomposites [9].
Figure 2. World hemp fiber production, 1961–2013. Source
Figure 3. European Union fiber and hempseed production, 1993–2013. Source: 
​From a building materials standpoint, hemp and other natural fibers have light weight, high strength to weight ratio, high insulating potential, and are more recyclable than conventional materials [16]. Hemp–lime construction can include hemp–lime concrete (hempcrete), natural fiber insulation, or hemp–lime stucco, with environmental and economic benefits [17]. Hemp–lime concrete is a mixture of a lime-based binder and relatively inexpensive hemp hurds, and is considered carbon negative [18]. Hemp–lime construction is used throughout Europe, but use of hurds for this purpose competes with the lucrative animal bedding market, which uses about half the hurds produced in the EU [9]. Hurds can be an economically viable alternative bedding for both large and small animals [19]. Hemp fiber also has potential as a biomass source, as described later in Section 7.5.
Breeding for fiber has a long history, with relatively modest gains anticipated in the near future. Hemp has limited potential to garner a significant market share as a natural fiber crop. Although there are many applications that can substitute hemp fiber for conventional products, the non-hemp versions are always more economical. Hemp pulp is about five times as expensive as wood pulp in Europe [9]. Cotton likely will remain a more attractive option for apparel. China has well established spinning facilities for natural fibers and coupled with a cheap labor force this makes establishment of a hemp textile industry outside of China problematic. There is a very dedicated niche market for environmentalists interested in hemp building materials, hemp clothes etc., but such uses are not likely to increase greatly. USA imports of hemp yarn have increased over the past couple of years [20] (Figure 4), but in general USA hemp fiber imports are relatively stagnant compared to hempseed imports (Figure 5). Even with significant subsidies, European hemp fiber production has not greatly expanded, and it is highly unlikely that either Canada or the USA would consider any form of hemp subsidy.
Figure 4. Value (USD) of USA imports of hemp fiber products, 2006–2015. 
Figure 5. Value (USD) of USA imports of hempseed and hemp oil products, 2006–2015. Source:
​3.2. Oilseed
Hempseed has been used as organic hemp foods for at least 3000 years for both humans and livestock [12], and hempseed was one of the “five grains” of ancient China [21]. Hemp oil was also used as a lighting oil, and for making soap, paints and varnishes in the past. Twentieth century usage of the grain was confined mostly to bird seed, and oilseed land races of hemp were abandoned. Relatively recently, oilseed cultivars were bred in both Europe and Canada [22]. There is limited evidence that significant domestication occurred in the past specifically for harvest of seeds for human consumption, although a few land races in China have large seeds used as snack food. By comparison, most domestication for low-THC hemp was for fiber characteristics. In the last two decades, there has been increased selection specifically for seeds, and the few cultivars that have been developed represent only a limited amount of the potential for oilseed qualities and productivity. Hulled hemp seed, canned or vacuum-packed, recently has become a popular food for human consumption. The gritless seed meal produced by hulling differs from the oil-poor seed cake remaining after oil has been expressed, which also has been referred to as seed meal [4].
Vegetable oils extracted from seeds can be used as food, biofuel, nutritional supplements, and a wide variety of industrial applications. However, at present hempseed and hempseed oil is economically significant mostly as a minor specialty crop furnishing a niche food market. About 90% of the edible oil production worldwide comes from palm (Arecaceae spp,), soybean (Glycine max (L.) Merr.), canola (Brassica napus) and sunflower (Helianthus annuus L.) [23]. Hempseed oil can be pressure-extracted on either a small or large scale, using screw or hydraulic presses, which extract 60%–80% of the oil [24]. The residual pumace can be pressed into an ‘oil cake’ (seed cake) which in reality is a de-oiled cake. The protein-rich seed cake remaining after oil has been expressed has been shown to be an excellent livestock feed [25]. Hempseed oil also can be extracted with n-hexane solvents [26], although this typically results in a contaminated final product unsuitable for human food or animal feed [27]. It is possible to use supercritical CO2 extraction to produce food quality hempseed oil [28], but it is costly and time consuming.
Hempseed oil is a vegetable or fixed oil from the seed (achene), and is best used as a fresh uncooked (salad) oil. The smoke point of hempseed oil is approximately 165 °C, which is too low for high temperature cooking or frying [12]. Approximately 80% of the fatty acids in hempseed oil are unsaturated [29], giving it a relatively short shelf life, which can be extended by storing in dark containers and by refrigeration.
Hempseed oil is rich in both omega-6 and omega-3 essential fatty acids, with a ratio of omega-6 to omega-3 considered optimal for human health [22,29]. Hempseed oil contains significant quantities of γ-linolenic acid (GLA), and smaller concentrations of other fatty acids of dietary significance [30]. Aging, diet and pathology may impair GLA metabolism, and supplementation in the diet can have a positive effect on many disorders [31]. Antioxidant tocopherols of the Vitamin E group are present in hempseed at higher concentrations than flax and canola seed oils [32], with about 80% of tocopherol present as γ-tocopherol [24,33]. Sterols up to about 0.7% of the oil are present in hempseed oil [24], and have a desirable antioxidant function. Phenolic compounds also are effective antioxidants providing cardio-protection and anti-inflammation benefits. Hempseed is rich in phenolics, with almost a four-fold range in concentration among current cultivars [34].
As with any grain crop, the primary breeding goal is increased yield, which must include selection to reduce seed shattering. Most breeding for oilseed characteristics has taken place in the past decade and it is likely that significant advances in oilseed composition can be made in the near future [12]. Oilseed characteristics of accessions and cultivars have been evaluated in Canada [35], China [36], Germany [37], Pakistan [38], and Romania [39]. One essential goal of any breeding program is to keep THC levels as low as possible. The United Kingdom prohibited marketing of the very popular oilseed cultivar, FINOLA, in January 2016 for exceeding the authorized THC content two years in a row [40], however the European Commission decision to authorize the prohibition was recently repealed [41]. It appears that a number of compositional traits are significantly influenced by environment, particularly latitude. Mölleken and Theimer [42] determined that hempseed grown in northern regions has a much higher concentration of GLA, compared to hempseed from more southern regions.
Currently, oilseed hemp is not competitive with linseed (Linum usitatissimum) for manufacturing oil, neither is it competitive with sunflower or canola for edible vegetable oil [12]. Nevertheless, economic prospects for a hemp oilseed crop in North America are promising, as the demand for hempseed products (seed, oil, and oil cake) is steadily increasing [20] (Figure 5). USA hempseed imports increased from $29 million in 2014 to $54 million in 2015, and hemp oil cake imports doubled over that period to $16 million. Total USA imports of seed, oil, and oil cake products exceeded $75 million in 2015. Hempseed production in the European Union (EU) has increased greatly [10] (Figure 3), and was as high as 73,450 tonnes in 2012. However, unlike Canada where hempseed is mainly employed as human food, in Europe the seed has been predominantly employed as livestock feed.
3.3. Pharmaceuticals
Cannabis contains a relatively unique class of terpenophenolic compounds—the cannabinoids. There are well over 100 different cannabinoids [43] produced in epidermal trichomes, but few are present in appreciable quantities, and relatively few have adequate pharmacological data available. Trichomes are epidermal appendages present on aerial parts in most plant species with many proposed functions, usually considered protection against predators [44,45]. There are several classes of epidermal secretory glandular trichomes in Cannabis, all of which produce cannabinoids [46]. Most THC is located in the resin heads of capitate-stalked glandular trichomes [47]. The highest concentration of cannabinoid resin is found in trichomes on the perigonal bracts which envelop the pistils and seeds. Glandular trichomes are also concentrated on the lower surface of young leaves, and on sepals and anthers. The primary cannabinoids produced in glandular trichomes are shown in Figure 6. The non-intoxicant cannabigerol (CBG) is the precursor of the other cannabinoids. Cannabichromene (CBC) is a non-intoxicant type found in trace amounts. There is generally an inverse relationship between THC and CBD in Cannabis; marijuana types produce primarily THC, while industrial hemp types produce primarily CBD [12]. Moreover, marijuana biotypes produce considerably more cannabinoids than do industrial hemp cultivars. Cannabidiol (CBD) antagonizes the intoxicant effects of THC [48]. Cannabinol (CBN) is a degradation product (Figure 6), not found in appreciable quantity in fresh plants. The THC in stored marijuana gradually converts over time to CBN, which is estimated to have 10% of the psychoactive potential of THC [49]. Cannabidiol can be converted to THC by acid catalyzed cyclization, but this is not a practical method for generating THC.
Figure 6. Biosynthetic pathways of the principal cannabinoids. CBG = cannabigerol; CBC = cannabichromene; CBD = cannabidiol; THC = Δ9-tetrahydrocannabinol; CBN = cannabinol.

Marijuana is chemically characterized by high amounts of THC while hemp is characterized by high amounts of CBD, but the psychopharmacological distinction between THC and CBD is somewhat problematical. As discussed by Small [12], the pharmacological classification of marijuana is controversial, and numerous terms have been applied to it and to THC in particular. These include psychedelic (mind-manifesting or consciousness-expanding), hallucinogenic (hallucination-producing), psychotomimetic (psychosis-imitating), illusinogenic (illusion-producing), psychodysleptic (mind-disrupting), psychoactive (altering sensation, mood, consciousness or other psychological or behavioral functions), psychotropic (mind-altering), and psychotomimetic (mood-altering). Several of these terms apply to CBD, not just to THC. A psychoactive drug acts primarily upon the central nervous system where it alters brain function, resulting in temporary changes in perception, mood, consciousness and emotion. A psychoactive drug is a psychotropic substance. Since CBD has anti-anxiety, anti-psychotic, and anti-depressant effects, it is correctly considered a psychoactive drug [50].
Cannabidiol was first isolated from Cannabis in the late 1930s [51], and has since been found to have therapeutic potential for disorders such as inflammation and anxiety, and also has potential as a neuroprotective agent and an antioxidant [52,53]. Along with CBD, other minor cannabinoids such as cannabidiolic acid (CBDA), tetrahydrocannabinolic acid (THCA), and cannabidivarin (CBDV) have shown efficacy for relief of nausea and emesis [54]. Cannabidiol also has been used to treat arthritis, cancer, diabetes, neurodegenerative diseases and pain [23]. Indeed, CBD has many more medical applications than THC [23], and since CBD is the principal cannabinoid of hemp it is arbitrary to refer only to high-THC biotypes of C. sativa as “medical cannabis”. Oilseed cultivars produce more flowers than fiber cultivars, and since the principle source of resin is from flowering tops, oilseed cultivars are a much more promising source of CBD than fiber cultivars [55]. At present, however, selected biotypes are being employed to produce CBD commercially—strains that not only produce mostly CBD by comparison with the yield of THC, but also produce much more CBD than conventional industrial hemp cultivars.

Lessons from Novel Field Crops in North America in Recent Decades
Hempseed production has been relatively successful in Canada. There are numerous claims that industrial hemp could transform the economy of the USA in a beneficial way, but it is worth keeping in mind that there has often been excessive enthusiasm for “new”, “diversification”, or “novel” crops. While there is apparently good potential for expansion of the hemp industry in North America, this also has thought to have been the case for many novel field crops over the past 50 years. There have been very optimistic claims for a number of crops publicized as having remarkable potential, but very few if any actually reached that potential (Table 1). Some of them have experienced little research and development, although most have surfaced in multiple decades of recurrent interest. Novel crops are often region-specific and best suited to a particular environmental niche. There are a few novel field crops suitable for growing across many different soil environments in multiple regions of North America. Some of these are annual crops that are not subject to winter conditions, while a few are perennial crops that have evolved ecotypes over decades or centuries that are better adapted to local environmental conditions. The most outstanding example for perennials is switchgrass (Panicum virgatum L.), with ecotypes evolved to fit a wide range of geographical diversity [56].

Crops such as camelina (Camelina sativa (L.) Crantz), kenaf (Hibiscus cannabinusL., Malvaceae), meadowfoam (Limnanthes alba Benth.), and teff (Eragrostis tef(Zucc.) Trotter) have all received some USA federal funding to hasten development and expansion of these crops, but acreage is shrinking due to a lack of market interest for all but teff. Novel crops primarily used for forage, such as comfrey (Symphytumspp.) and kura clover (Trifolium ambiguum M. Bieb.), typically do not receive any funding assistance and interest fades. An exception is brown-midrib (BMR), reduced lignin mutants, such as BMR pearl millet [Pennisetum glaucum (L.) R. Br.] [57]. Commercial interest over decades gradually resulted in research and development, and eventually led to niche markets for BMR pearl millet, BMR sorghum × sudangrass (Sorghum bicolor (L.) Moench) × (Sorghum sudanense Piper), and BMR corn (Zea mays L.).
The most infamous example of a novel field crop promotion prior to an established market was Jerusalem artichoke (Helianthus tuberosus L.). In the 1980s, midwestern USA farmers were assured that there would be a market for the tuber and were convinced to plant a relatively large area to the crop in an agricultural pyramid scheme spanning several years [58]. Profits were realized by the original distributors and a few of the initial farmers, who sold seeds to subsequent levels of the pyramid. A market never materialized and most of the crop was ruined and production abruptly terminated.
While USA federal funding assistance has helped some of the novel field crops in Table 1 reach a niche market status, even massive federal funding assistance in the case of biomass crops has not resulted in widespread production, simply due to the shortage of market demand. For the novel field crops in Table 1, we are requiring production in excess of 1000 ha in North America to consider it a niche market. The Biomass Crop Assistance Program (BCAP) was created by the US Congress in 2008 to meet the feedstock challenges of an expanding commercial-scale cellulosic biofuel industry, but “numerous headwinds continue to retard the development of that industry.” [59]. Funding for BCAP peaked at nearly $250 million in 2010, reduced to $11.5 million in 2015. While there is a considerable area of switchgrass grown for conservation or forage uses, most of the USA switchgrass and Miscanthus (Miscanthus × giganteus J. M. Greef and Deuter ex Hodk. and Renvoize) acreage grown for biomass is subsidized by BCAP. No amount of general public interest or funding support for a novel crop will overcome the lack of a market for its products.
Industrial hemp is one of the novel annual field crops with a relatively wide range of adaptation across North America. While it is possible for wild-growing Cannabis to survive in any province or state, domesticated cultivars of hemp are less stress tolerant [7]. Producing economic yields of hemp fiber or seed requires a moderate climate with a productive soil and plenty of water. Novel crops typically have agronomic, processing/conversion, economic, and/or social issues that prevent them from achieving their potential, and hemp faces all these issues to some extent. Although USA federal funding assistance has ranged from none to massive amounts for novel field crops, none of these crops have yet to achieve widespread adoption across the country. It is unlikely that hemp production would be significantly subsidized in either Canada or the USA. Although no barriers exist for USA multinationals to invest in hemp elsewhere, such investment has been minimal [60]

Hemp Production in North America
Detailed agronomic recommendations for Kentucky and Ontario [61,62] are available in the literature and key points are summarized here. Only hemp cultivars approved by Health Canada are allowed to be planted commercially in Canada. These cultivars mostly originated from Europe, although there is very recent breeding of oilseed cultivars in North America. The cultivar FINOLA has become the most popular cultivar grown in Canada. While some current cultivars will most likely prove adequate in some regions of the USA, there will be a need to develop cultivars better suited to specific regions and climates. Along with breeding for improved seed or fiber yields, it will remain critical for all cultivars to produce plants containing less than 0.3% THC. Dioecious, monecious, and female dominant cultivars are available. Commercial seed stocks of so-called monoecious cultivars typically develop plants with both male and female flowers, although some plants have exclusively male or exclusively female flowers [23]. Commercial seed stocks of female-dominant cultivars predominantly produce plants with female flowers.
Soils ideally suited to hemp production are comparable to corn-growing soils: they are well-aerated loams with high fertility and high organic matter. Marginal types of soil that are unproductive, compacted or poorly-drained are inappropriate. Fertility requirements for hemp production are similar to a high-yielding crop of wheat, with up to 110 kg·N·ha−1 suggested [62]. For fiber production, seeds are normally sown in rows spaced from 7 to 20 cm apart. For seed production in Europe, seeds have been planted in rows spaced 15–18 cm apart, but closer planting is best for the popular but quite short cultivar FINOLA. Detailed information on agronomics of FINOLA is available [63]. Seeding depth should not exceed 3 cm, and seeding rate is very cultivar specific and varies widely. Fiber cultivars are seeded at 45 to 70 kg·ha−1, while oilseed cultivar seeding rates range from 10 to 45 kg·ha−1 [4]. Hemp in a continuous monoculture risks buildup of weeds and insect pests [64] and a four-year crop rotation with hemp grown for one year is recommended.
Most hemp cultivars are photoperiodic, and for these the earlier the planting date, the more vegetative growth that will accumulate, as hemp is day-length sensitive and flowering is triggered with the onset of shorter days in late July [4]. However, FINOLA, the most widely grown cultivar, is day-length insensitive (“day neutral”, “autoflowering”), although drought will hasten maturation. A fiber crop of hemp is harvested in the early flowering stage, and retting of the fiber is usually done in the field, requiring several weeks. Fiber can be baled with conventional equipment at around 15% moisture, and bales must be stored indoors. Hempseed is harvested when seed starts to shatter from the indeterminate inflorescence, when about 70% of the seed is ripe [4]. Short cultivars are the easiest to combine and minimize machinery wear [4]. By far, birds are the greatest pests for hempseed production in North America, and can be devastating in small fields of hemp.
In Canada, hemp production occurs from eastern to western Canada, but is concentrated in the prairie provinces. The Corn Belt is likely the best region in the USA for hemp production [4], although Kentucky has had very good success with hemp in the past. The requirement for good soils, relatively abundant rainfall, and a moderate climate will restrict opportunities for hemp production in the southeastern, southwestern and western USA. Soil requirements may eliminate a large percentage of cropland in the northeastern USA from potential hemp production, due to marginal, inadequately-drained soils.

Environmental Impact

6.1. Biodiversity
Montford and Small [65,66] proposed a biodiversity friendliness index with 26 parameters with either negative or positive effects on biodiversity and/or the environment, and applied it to a selected group of major crop species. Hempseed production ranked highly, exceeded as a field crop only by alfalfa (Medicago sativaL.), although alfalfa was the only perennial forage crop included in the example comparison. Hemp does have many positive biodiversity features relative to other annual row crops, but does not compare well to perennial or winter annual forage sod crops that are often composed of multiple species, including Nitrogen-fixing legumes. Hemp is a weedy crop by nature, escaping easily, and weeds reduce biodiversity. On the positive side, hemp does not require pesticides, which reduce soil organism biodiversity and may threaten survival of some species. Hemp also produces environmentally-friendly manufactured products, as well as beneficial products for wildlife.

Environmental Sustainability
The environmental benefits of hemp are often exaggerated in the popular press; hemp is not “the key to our green future”. Hemp is an annual row crop and as such is susceptible to significant soil erosion and soil nutrient depletion, and also has a relatively high water requirement. In particular, the relatively high nitrogen (N), phosphorus (P), and potassium (K) requirements of a hempseed crop tend to refute the excessive sustainability claims for hemp. Hemp is naturally adapted to employing mammalian manure as fertilizer, and was generously fertilized with manure in past times. It has the potential of efficiently employing stocks of livestock manure, although synthetic fertilizers, which are less desirable from a sustainability perspective, are usually employed in developed nations. One of the primary environmental claims for hemp is the potential to save trees, but da Siva et al. [13] concluded that hemp fiber presents higher environmental impacts than eucalyptus paper in all of the environmental categories they analyzed. However, hemp produces environmentally-friendly manufactured products, including thermal insulation, carbon-sequestering bioplastics, and lightweight concrete substitutes that reduce transportation costs [23]. Hemp does have a deep root system that decays rapidly to provide both soil aeration and fertilization.
Hemp provides both food and fiber which put it in the essential category for human survival, as opposed to luxury or non-essential crops. Hemp fiber products such as wool, fiber panels, cement and plastics can fix carbon for relatively long periods [67], but these uses are likely to remain a very small portion of the total market. Hemp does have potential as a soil bio-remediation crop [68]. Since North American hemp production and processing will involve relatively high fertilizer inputs, as well as machinery in place of the manual labor used in other countries, the energy to produce and process the crop will be significant.


Economic Forecasts
When it became evident during the last decade of the twentieth century that hemp cultivation was being promoted, several economic analyses were conducted in various countries [55,69,70,71,72,73,74,75,76]. Vantreese [60] noted that without a viable processing industry, profit projections for USA-grown hemp were extremely speculative. In 2000, USDA Economic Research Service [77] concluded that hemp markets are likely to remain small, and uncertainty about long-term demand and the potential for oversupply minimized the chance for hemp as an economically viable alternative crop in the USA. These analyses are more or less obsolescent, since hemp cultivation has actually been revived in many countries, and the resulting hemp products have been tested in the marketplace for the last two decades. Fortenbery and Bennett [78] concluded that hemp is slightly more profitable than traditional grain crops, but less profitable than specialty crops, and on the whole is rather discouraging of future development. Robbins et al. [79] examines the potential in Kentucky. Johnson [80] concluded that small scale, profitable niche markets for hemp products could make hemp an economically viable alternative crop for some regions of the USA. Recent reviews are clearly relatively optimistic. Hemp is now grown commercially in about three dozen countries, with the notable exception of the United States (although this seems about to change). Earlier economic analyses generally failed to foresee that hempseed rather than fiber applications would become the most promising aspect of industrial hemp development. A variety of imaginative, innovative hemp fiber and hempseed products have appeared in the marketplace in the last two decades, and have provided considerable impetus to increasingly promising industries 

In past centuries, hemp was a leading cordage and textile crop, but with the advent of cotton, tropical fiber crops and modern synthetic fibers, such uses are confined to a niche market, attractive to a small number of consumers who like the “green image” and marijuana association of the plant. China, the world’s leading producer of hemp, has an established tradition of producing high-quality textile-grade fiber and textile products [23]. China’s hemp fiber industry has the advantages of cheap labor and regulatory tolerance of water retting, which is environmentally unacceptable in most of the West. Attempts to re-establish a hemp textile industry in Europe using new technology have not been cost-effective to date, and it is likely that China will remain dominant in the foreseeable future in producing high-quality hemp textiles for apparel.
In Europe in the last two decades, there has been an economic resurgence of hemp fiber in the marketplace, based on non-traditional usages, particularly in the production of a very wide range of pressed fiber and insulation products, and plastics. In Europe, the greatest success of hemp fiber products has been in the automobile, construction, and agriculture industries [23]. Although hemp fiber has superior characteristics for particular applications, market penetration has been due, in substantial part, to subsidization (related to “green support” policies). With the diminishment of such support, the future success of such products is uncertain. A major economic concern of growing hemp for fiber is the cost of transportation to a processing center. As found with most biomass energy crops, hemp is a bulky crop and it is not cost-effective to ship hemp far from a processing plant. The Illinois Hemp Task Force [81] noted that a processing plant for hemp fiber needs to be a maximum of 80 km away.

Hemp has far more potential as an oilseed crop than as a fiber source. Canada has become the leading country of hempseed production since industrial hemp was reintroduced in the country in 1998. In Europe, some dual purpose cultivars (harvested for both oilseed and fiber) have been cultivated. However, it is clear that this compromises the quality of the two crops. In very recent times, the EU has realized that its investment in fiber hemp has been a miscalculation, and it is investing in oilseed hemp. According to Bio-based News [82] “A hemp seed market potential linked to a penetration of 5% of the European nut market would signify an added market value of €1 billion/year ($1.14 billion/year)”.
The dietary advantages of hempseed and hempseed oil are quickly gaining acknowledgment in North America, and sales of hempseed products are rapidly increasing. China can produce relatively inexpensive hempseed, but imported seed must be sterilized, which adds cost and lowers grain quality. Traditional use of hempseed oil for manufacturing of paints and lubricants is obsolete. Since most hempseed is now grown for human consumption, and the seed and oil have limited shelf life, domestic production is advantageous to avoid rancidity prior to consumption [23]. Also, there is a rapidly growing market for organically-produced foods in North America, and organic certification of hempseed from outside North America is problematic.
The key need of the oilseed hemp industry is the development of high-yielding cultivars to increase the competiveness of hempseed in relation to other oilseeds. The present productivity of oilseed hemp—about 1 tonne/ha under good conditions, occasionally 1.5 to 2 tonnes/ha, is not yet sufficient for the crop to become competitive with major oilseeds. An average productivity of at least 2 tonnes/ha will be necessary to transform hempseed into a major oilseed, and this breeding goal is achievable. At present, losses of 30% of the seed yields are not uncommon, so that improvements in harvesting technology should also contribute to higher yields [4]. Hemp food products cannot escape their niche market status until the price of hempseed rivals that of other oilseeds, particularly rapeseed, flax, and sunflower [4].
Even though a hempseed industry infrastructure has been in place in Canada for 15 years, its stability may be severely tested by future hempseed production in the USA, as most Canadian production is exported to the USA. Once the USA begins production, potentially up to 30 states will anticipate making a profit on hemp by selling to the surrounding states. It may take 10 or 15 years for the industry in North America to readjust to the new paradigm. The uncertainty in yields, production costs, harvesting and processing equipment, and production characteristics will all increase the risk of hempseed production in the USA, until it becomes a standard crop [4].

The resin of C. sativa is usually dominated by CBD, THC or both. While most contemporary medicinal and recreational strains are predominantly dedicated to THC, CBD has considerable medicinal potential, indeed exceeding the likely value of THC [23]. Since the resin of hemp cultivars is dominated by CBD relative to THC, it is obvious that these varieties are a potential source of this invaluable cannabinoid. Because oilseed cultivars produce more flowers than fiber cultivars, and the inflorescences or infructescences are where most cannabinoids are produced, these cultivars are a logical source for CBD. Moreover, the residue after the seeds are harvested can be employed to salvage CBD. The use of industrial hemp for the production of CBD has not received much consideration yet, although there is commercial interest in using field-grown plants for this purpose [23]. Since the hemp industry is already growing plants outdoors under license, with relatively small security requirements, why should it not also be permitted to harvest the CBD? The industrial hemp industry is not allowed to do so at the moment in most countries, but the large profit potential of CBD will very likely lead to harvest of this non-intoxicating cannabinoid. According to Bio-based News [82], in Europe alone “CBD has a minimum (annual) market penetration potential of €24 million ($27.4 billion)”. At present, some biotypes that are not only rich in CBD but produce considerably more than conventional oilseed cultivars are being employed in some countries. Whether growing conventional oilseed cultivars for a dual crop (seeds and CBD) is a better strategy remains to be determined.

​It has been contended that hemp is notably superior to most crops in terms of biomass production, but van der Werf [83] observed that the annual dry matter yield of hemp (rarely approaching 20 t/ha) is not exceptional compared to corn, beet or potato. Meijer et al. [84] also noted that there are constraints to the biomass production of hemp. However, most hemp varieties have been selected for production of fiber, not for biomass. Hemp has been rated on a variety of criteria as one of the best crops available to produce energy in Europe [85]. Hemp, especially the hurds, can be burned as is or processed into charcoal, methanol, methane or gasoline through pyrolysis (destructive distillation). Hemp could be used to create cellulosic-based ethanol [86,87]. González-García et al. [88] showed that ethanol derived from hemp hurds under some scenarios could be practical. However, conversion of hemp biomass into fuel or alcohol is impractical in areas where there are abundant supplies of wood, and energy can be produced relatively cheaply from a variety of sources. Prade et al. [89] concluded “The main competitors for hemp are maize and sugar beets for biogas production and the perennial crops willow, reed canary grass and Miscanthus for solid biofuel production. Hemp is an above-average energy crop with a large potential for yield improvements”.
It is possible to convert hempseed oil to a biodiesel fuel by transesterification with methanol [90,91] or ethanol [92], but with current prices and environmental incentives it is not economically competitive as a fuel. One advantage of hempseed oil is that it has a lower freezing point than saturated oils, better for biodiesel engines operating in cold environments [27]. In Europe, subsidization has been an important stimulus for the continuing development of biomass crops. In North America, biomass has not proven to have sustainable investment value, and the huge production of lumber waste and crop residues represents considerable competition for crops cultivated specifically for biomass.

Coupling and Decoupling of Hemp and Marijuana
Marijuana’s impact on hemp development in North America can be summarized as essentially catastrophic. Hemp was outlawed in North America nearly 80 years ago because it was confused with marijuana. Some believe, without any convincing evidence, that it was part of a paper manufacturer conspiracy to keep hemp from replacing timber [93]. An often-expressed concern over legalizing hemp in the USA is that marijuana plants would be hidden amongst hemp plants. However, today most marijuana is harvested from seedless plants (seedless marijuana is termed “sinsemilla”) since the absence of seeds builds up the THC concentration, and knowledgeable marijuana growers would not grow their plants where they will be pollinated and produce seeds [23]. Both Canada and Europe have developed effective licensing systems for monitoring hemp production, and the absence of any reports linking hemp farms to the drug market over the past 20 years points out the success of such regulations.
Many government officials and citizens in the USA believe that the unprecedented massive support by non-farmers and politicians for legalization of hemp has less to do with it as it does with marijuana. Two surveys were conducted in the USA in the 1990s featuring hemp. When asked to agree or disagree with the statement “If we legalize industrial hemp, pretty soon we would legalize marijuana”, 71% of Kentucky residents who responded agreed with the statement [94]. Vermont residents were asked about the often mentioned concern that legalization of hemp production would inevitably lead to legalization of marijuana [95]. One third of respondents indicated that they were concerned or very concerned that this could happen. The Minnesota Department of Agriculture funded two surveys in 2014 regarding industrial hemp, a national survey of state departments of agriculture and a survey of Minnesota institutions of higher education [96]. Thirty-four out of 50 states responded to the survey, and one of the five questions focused on marijuana. Seventeen states replied that they had medical marijuana laws, and seven states replied that they had leniency laws for marijuana convictions. For the Minnesota colleges and universities survey, researchers were asked if they would participate in a pilot hemp program and to estimate the funding required. Half of the respondents said they would like to participate and estimated budgets of $20,000 to $500,000 would be required for hemp research.
It appears that many early industrial hemp advocates were motivated by the prospect of legalizing marijuana. The popular classic monograph promoting hemp and marijuana by Jack Herer first published in 1985 [93] has a very consistent theme that hemp is marijuana. Many now believe that the hemp industry has matured and is currently dominated by those who view hemp as the agricultural and industrial crop that it is, and see hemp legalization as a different issue from marijuana legalization [97]. Several of the USA state laws that have been recently proposed or passed, however, continue to link hemp to marijuana legislation. Also, the large number of states that have introduced hemp legislation, some if not many with inferior hemp growing environments, throw suspicion on the process. As noted by Caulkins et al. [98], “But it’s hard to imagine that the passionate advocacy of industrial hemp is unrelated to its link to drug policy”.
The political link between hemp and marijuana continues online, as marijuana-promoting websites often include hemp discussions. For example,[99] lists information on state sponsored hemp trials under “Industrial uses of marijuana”, and the site [100] is strictly a pro-marijuana website. There is concern expressed by USDEA and others that efforts to legalize hemp are a front for individuals and organizations whose real aim is to see marijuana decriminalized [80]. While hemp-promoting websites clearly distinguish hemp issues from marijuana issues (e.g., [101,102,103]), marijuana-promoting websites often blur the distinction.

 Law Reviews
Law Reviews or Law Journals are scholarly journals focusing on legal issues, containing articles, notes or comments to defend a particular point of view. There are numerous papers defending the viewpoint for legalization of industrial hemp in the USA, but none can be found with an opposing viewpoint. Pro-hemp Law Review discussions can be found from the following states: CA [104,105]; CO [106]; IN [107]; KY [108,109]; MO [110]; ND [111]; OK [112]; and OR [113]. There is a consistent enthusiastic theme throughout all these discussions: legalizing industrial hemp in the USA is in the public interest. Many of their arguments are supported by oft-repeated inaccurate or debatable statements. Most of these papers originate from individuals with little or no experience with field crops or crop production systems, calling their motives into question.

Current Status of Industrial Hemp
Canada has had a tradition of profitable oilseed products, including Canola, flaxseed, mustard, soybean, safflower, and sunflower, and therefore has the processing technology to take full advantage of new oilseed crops, such as hemp [4]. Canadian hemp production has been steadily increasing, after some market adjustments during the early years (Figure 7) [114], and almost all of this production is oilseed hemp. While some hemp for fiber has been grown, it cannot compete with China’s production of low cost hemp textiles, or Europe’s heavily subsidized hemp industry. Canada lacks a fiber crop industry and the processing technology that goes with it. Dual purpose crops for both fiber and oilseed have also been grown to a limited extent to produce modest seed yields combined with relatively low quality fiber production. Profitability of hempseed is much greater than that of fiber, and market forces are encouraging the emphasis on hempseed over fiber production.​

Figure 7. Hemp-licensed area (ha) in Canada since hemp production permits were available beginning in 1998. Source:
Beginning as early as 1999, states began to pass laws governing hemp cultivation (Table 2), assisted by the full support of the powerful American Farm Bureau Federation. As of October 2016, 30 states have passed laws on industrial hemp. Approximately half of the state laws permit farmers to be licensed to grow hemp. All hemp cultivation is contingent on approval from state agencies and from USDEA, as hemp remains linked with marijuana as a federally-controlled crop. Thirteen additional states are attempting to pass laws, and hemp legislation to-date has failed in six states. In three states, hemp legislation is contingent upon changes in federal law governing industrial hemp. All states are using the threshold concentration of 0.3% THC to legally distinguish hemp, except for West Virginia, which set the threshold at 1.0% THC. Two states, Missouri and Utah, specifically allow the use of hemp extracts or CBD to treat individuals with epilepsy. Hawaii established a program to study the potential use of hemp as a phytoremediator and as a biofuel.
Ohio is the only state that has not attempted to pass hemp legislation to date, although several organizations are attempting to get the Medicinal Cannabis and Industrial Hemp constitutional amendment on the Ohio ballot in 2017. Approximately 300 industrial hemp bills have been proposed in state legislatures to date. The extraordinary widespread political support for a novel field crop is unprecedented and exceeds the actual potential of the crop. Eight states have conducted feasibility studies on hemp, with a range of very positive to negative conclusions on the economic feasibility of hemp production.
9.2.1. State Reports on Hemp
In general, state reports provide a history of hemp in the USA and a summary of the agronomy of hemp. They also describe the versatility of hemp for purposes such as construction materials, paper, textiles, plastics, food products, and biomass feedstock. Several reports [5,55] strongly focus on fiber production, particularly in the Pacific Northwest. The North Dakota study [72] focuses on oilseed production. Based upon the evidence presented, Illinois Task Force members concluded that there is potential for industrial hemp to be an important alternative crop [81]. A Kentucky report [75] concluded that there are a number of specialty or niche markets for hemp products, and that the economic impact for Kentucky would be greatest if the state becomes the main source for certified hempseed in the USA.
A report on the economic viability and political concerns for industrial hemp generated for the Hawaiian legislature [115] implies that hemp has high profitability, as well as numerous sustainable agriculture advantages. The Hawaiian paper also points to the large number of groups, companies and individuals who are supporting hemp cultivation as evidence against the common misconception that “The effort to legalize hemp is a ruse to legalize the drug”. In general, most state studies are very positive about the potential of hemp in their state, but studies tend to focus on fiber uses and not seed or pharmaceutical uses, and most of these studies are out of date. State hemp studies in Maine [116] and Arkansas [117] that do not have very positive conclusions are not included under state-sponsored hemp trial lists on websites such as [99]. Environmental or economic concerns limit the potential of hemp, according to Maine and Arkansas reports.
9.2.2. Possible Scenarios for the USA
Figure 8 shows three possible scenarios for the USA, depending on the ability of the North American hemp market to expand to absorb production. Even the most optimistic scenario (A) results in about half of the states failing in their attempt to establish a hemp industry in their state. From an economic investment standpoint, USA entrepreneurs and states appear to be assuming the market will be supply-driven, not demand-driven. The most likely scenario may lie between “A” and “B”, with a small niche market for hemp fiber, coupled with a considerably larger market for hempseed products. Any of these scenarios (Figure 8) will have at least a short term negative impact on the Canadian hemp industry.

Figure 8. Possible industrial hemp scenarios in the USA.


The promise of industrial hemp is somewhere between “Hemp is just a stalking horse for marijuana” and “Hemp can save the planet”. There is no other example in history of a novel field crop being so greatly impacted by socio-politics. While interest in industrial hemp in Canada is relatively well matched to its potential as an oilseed crop, the current hype over industrial hemp in the USA exceeds the actual short-term potential of this field crop. One of the primary reasons for excess enthusiasm in the USA appears to be the tight link between many marijuana supporters and the movement to reintroduce hemp cultivation in the USA—many hoping that legal hemp cultivation will help pave the way to decriminalization of marijuana. There are clearly two camps regarding hemp promotion in the USA and it is impossible to completely separate them or quantify their relative proportions.
Although a small amount of hemp is grown for fiber in Canada, the fiber market has a much more limited potential compared to oilseed in North America. European hemp production, initially mostly fiber but now with significant hempseed production, is maintained through government subsidies. China, where hemp originated, has the capability to produce large quantities of very competitively priced hemp fiber, primarily due to inexpensive labor. While there will likely be a small, dedicated niche market for hemp fiber in North America, there is insufficient evidence to suggest that a large market demand will materialize to meet a large supply. The hemp oilseed market is stable and steadily increasing in Canada, and the USA has the potential to establish a similar market once industrial hemp is legally distinguished from marijuana and declassified as a Schedule 1 controlled substance.
Like all grain crops grown in the USA and Canada, hemp production demands relatively intensive management for success, and many potential industrial hemp growers in the USA do not appreciate the level of crop management required. Seedbed conditions, seeding rates, dates, and harvest dates are all impacted by the hemp germplasm used. Grain crop production is not for the hobby farmer, and the four-year crop rotation necessary to minimize pest buildup requires a significant supply of cropland. After legalization of hemp in the USA, hemp farmers may face the serious economic consequences of oversupply, as did many farmers who were encouraged to establish switchgrass in anticipation of the cellulosic ethanol industry over the past 10 years. The North American hemp oilseed market will quickly become saturated if production is initiated in multiple states. Hemp fiber production will remain a small niche market, as demand is likely to remain modest and will face stiff competition from both China and the EU. Hemp oilseed supply and demand will eventually recover from the influx of USA hemp oilseed, but may be disruptive to farm economies for an extended period.
Canada has successfully established and maintained stable/increasing hemp oilseed production after the first 8 years of market adjustment. Canadian society appears to clearly understand the distinction between industrial hemp and marijuana, and the hemp industry in Canada seems relatively immune to marijuana politics. United States society, on the other hand, is having a difficult time separating hemp from marijuana politics. The widespread and aggressive championing of industrial hemp overshadows the significant legitimate potential of hemp as a field crop in the USA, with numerous marijuana advocates promoting declassification of hemp.
More than 30 US states could attempt to establish an industrial hemp crop industry following deregulation, greatly increasing the potential for hemp market chaos in North America. Since the drive for hemp production is coming from individual states, there is little consideration of basic supply and demand economics. Oversupply is highly likely, resulting in a production crash much more severe than was observed in Canada during the early years of the industry. The most opportunistic scenario for hemp in North America is oilseed production coupled with CBD extraction from hemp stover and/or from floral parts of oilseed cultivars for pharmaceutical uses. Markets for small acreage crops are fragile, and good advice for North American farmers interested in hemp production is to identify buyers and a selling price before planting the crop.Conflicts of InterestThe authors declare no conflict of interest.References
  1. Available online: (accessed on 11 November 2016).
  2. Small, E. Cannabis: A Complete Guide; CRC Press: Boca Raton, FL, USA, 2016; in press. [Google Scholar]
  3. Small, E.; Cronquist, A. A practical and natural taxonomy for CannabisTaxon197625, 405–435. [Google Scholar] [CrossRef]
  4. Miller, R.L. Hemp as a Crop for Missouri Farmers: Markets, Economics, Cultivation, Law. Report to Agriculture Task Force, Missouri House of Representatives. 1991. Available online: (accessed on 14 October 2016).
  5. Ehrensing, D.T. Feasibility of Industrial Hemp Production in the United States Pacific Northwest; Station Bulletin 681; Oregon State University: Corvallis, OR, USA, 1998. [Google Scholar]
  6. Small, E.; Marcus, D. Hemp—A new crop with new uses for North America. In Trends in New Crops and New Uses; Janick, J., Whipkey, A., Eds.; ASHS Press: Alexandria, Egypt, 2002; pp. 284–326. [Google Scholar]
  7. USDA-NRCS. Plants Database. Natural Resource and Conservation Service, U.S. Department of Agriculture. Available online: = casa3 (accessed on 14 October 2016).
  8. Carus, M.; Sarmento, L. The European Hemp Industry: Cultivation, processing and applications for fibres, shivs, seed and flowers. European Industrial Hemp Association, May 2016; pp. 1–9. Available online: (accessed on 8 November 2016).
  9. Small, E.; Pocock, T.; Cavers, P.B. The biology of Canadian weeds. 119. Cannabis sativa L. Can. J. Plant Sci. 200383, 217–237. [Google Scholar]
  10. Carus, M.; Karst, S.; Kauffmann, A.; Hobson, J.; Bertucelli, S. The European Hemp Industry: Cultivation, Processing and Applications for Fibres, Shives and Seeds; European Industrial Hemp Association: Hürth, Germany, 2013; pp. 1–9. [Google Scholar]
  11. Cochran, M.J.; Windham, T.E.; Moore, B. Feasibility of Industrial Hemp Production in Arkansas; Report SP102000; Department of Agricultural Economics and Agribusiness, University of Arkansas, Division of Agriculture: Fayetteville, AR, USA, 2000. [Google Scholar]
  12. FAOSTAT3. Statistics Division, Food and Agriculture Organization of the United Nations. Available online: (accessed on 14 October 2016).
  13. Small, E. Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Bot. Rev. 201581, 189–294. [Google Scholar] [CrossRef]
  14. Da Silva Vieira, R.; Canaveira, P.; da Simoes, A.; Domingos, T. Industrial hemp or eucalyptus paper? Int. J. Life Cycle Assess. 201015, 368–375. [Google Scholar] [CrossRef]
  15. Suardana, N.P.G.; Piao, Y.; Lim, J.K. Mechanical properties of hemp fibres and hemp/PP composites: Effects of chemical surface treatment. Mater. Phys. Mech. 201111, 1–8. [Google Scholar]
  16. Yallew, T.B.; Kumar, P.; Singh, I. Sliding behaviour of woven industrial hemp fabric reinforced thermoplastic polymer composites. Int. J. Plast. Technol. 201519, 347–362. [Google Scholar] [CrossRef]
  17. Domke, P.V.; Mude, V.D. Natural fiber reinforced building materials. IOSR J. Mech. Civ. Eng. 201512, 104–107. [Google Scholar]
  18. Duffy, E.; Lawrence, M.; Walker, P. Hemp-lime: Highlighting room for improvement. Civ. Environ. Res. 20134, 16–21. [Google Scholar]
  19. Walker, R.; Pavia, S.; Mitchell, R. Mechanical properties and durability of hemp-lime concretes. Constr. Build. Mater. 201461, 340–348. [Google Scholar] [CrossRef]
  20. Bouloc, P. The uses of hemp for domestic animals. In Hemp: Industrial Production and Uses; Bouloc, P., Allegret, S., Arnaud, L., Eds.; CAB International: Wallingford, UK; Boston, MA, USA, 2013; pp. 260–262. [Google Scholar]
  21. U.S. International Trade Commission (USITC). U.S. Import and Export Data on Dataweb; U.S. International Trade Commission: Washington, DC, USA, 2016. Available online: (accessed on 14 October 2016).
  22. Huang, H.T. Science and Civilization in China, Vol. 6: Biology and Biological Technology, Part V: Fermentation and Food Science; Cambridge University: Cambridge, UK, 2000. [Google Scholar]
  23. Schultes, R.E. Random thoughts and queries on the botany of Cannabis. In The Botany and Chemistry of Cannabis; Joyce, R.B., Curry, S.H., Eds.; J. & A. Churchill: London, UK, 1970; pp. 11–38. [Google Scholar]
  24. Laakkonen, T.T.; Callaway, J.C. Update on FIN-314. J. Int. Hemp Assoc. 19985, 34–35. [Google Scholar]
  25. Matthäus, B.; Brühl, L. Virgin hemp seed oil: An interesting niche product. Eur. J. Lipid Sci. Technol. 2008110, 655–661. [Google Scholar] [CrossRef]
  26. Mustafa, A.F.; McKinnon, J.J.; Christensen, D.A. The nutritive value of hemp meal for ruminants. Can. J. Anim. Sci. 199979, 91–95. [Google Scholar] [CrossRef]
  27. Oomah, B.D.; Busson, M.; Godfrey, D.V.; Drover, J.C.G. Characteristics of hemp (Cannabis sativa L.) seed oil. Food Chem. 200276, 33–43. [Google Scholar]
  28. Callaway, J.C.; Pate, D.W. Hempseed oil. In Gourmet and Health-Promoting Specialty Oils; Moreau, R., Kamal-Eldin, A., Eds.; AOCS Press: Urbana, IL, USA, 2009; pp. 185–214. [Google Scholar]
  29. Aladic, K.; Jarni, K.; Barbir, T.; Vidovic, S.; Vladic, J.; Bilic, M.; Jokic, S. Supercritical CO2 extraction of hemp (Cannabis sativa L.) seed oil. Ind. Crops Prod. 201576, 472–478. [Google Scholar] [CrossRef]
  30. Callaway, J.C. Hempseed as a nutritional resource: An overview. Euphytica2004140, 65–72. [Google Scholar] [CrossRef]
  31. Leson, G.; Pless, P. Hemp seed and hemp oil. In Cannabis and Cannabinoids. Pharmacology, Toxicology, and Therapeutic Potential; Grotenhermen, F., Russo, E., Eds.; Haworth Integrative Healing Press: Binghamton, NY, USA, 2002; pp. 411–425. [Google Scholar]
  32. Deferne, J.-L.; Pate, D.W. Hemp seed oil: A source of valuable essential fatty acids. J. Int. Hemp Assoc. 19963, 4–7. [Google Scholar]
  33. Teh, S.-S.; Birch, J. Physicochemical and quality characteristics of cold-pressed hemp, flax and canola seed oils. J. Food Comp. Anal. 201330, 26–31. [Google Scholar] [CrossRef]
  34. Mölleken, H.; Mothes, H.; Dudek, S. Quality of hemp fruits and hemp oil in relation to the maturity of the fruits. In Proceedings of the Bioresource Hemp & Other Fibre Crops: Proceedings of the Symposium, Wolfsburg, Germany, 13–16 September 2000; Nova Institute: Hürth, Germany, 2000. [Google Scholar]
  35. Vonapartis, E.; Aubin, M.-P.; Seguin, P.; Mustafa, A.F.; Charron, J.-B. Seed composition of ten industrial hemp cultivars approved for production in Canada. J. Food Comp. Anal. 201539, 8–12. [Google Scholar] [CrossRef]
  36. Small, E.; Marcus, D. Hemp germplasm trials in Canada. Irregularly paginated. In Proceedings of the Third International Symposium Bioresource Hemp, Wolfsburg, Germany, 13–16 September 2000; Nova Corporation: Hürth, Germany, 2000. [Google Scholar]
  37. Chen, T.; He, J.; Zhang, J.; Zhang, H.; Qian, P.; Hao, J.; Li, L. Analytical characterization of hempseed (seed of Cannabis sativa L.) oil from eight regions in China. J. Diet. Suppl. 20107, 117–129. [Google Scholar] [PubMed]
  38. Kriese, U.; Schumann, E.; Weber, W.E.; Beyer, M.; Brühl, L.; Matthäus, B. Oil content, tocopherol composition and fatty acid patterns of the seeds of 51 Cannabis sativa L. genotypes. Euphytica 2004137, 339–351. [Google Scholar] [CrossRef]
  39. Anwar, F.; Latif, S.; Ashraf, M. Analytical characterization of hemp (Cannabis sativa) seed oil from different agro-ecological zones of Pakistan. J. Am. Oil Chem. Soc. 200683, 323–329. [Google Scholar] [CrossRef]
  40. Mihoc, M.; Pop, G.; Alexa, E.; Radulov, I. Nutritive quality of Romanian hemp varieties (Cannabis sativa L.) with special focus on oil and metal contents of seeds. Chem. Cent. J. 20126, 122–133. [Google Scholar] [CrossRef] [PubMed]
  41. Callaway, J. Basic information on FINOLA Agronomy for 2016. Available online: (accessed on 10 November 2016).
  42. Official Journal of the European Union. Decisions. Off. J. Eur. Union 201659, 7. [Google Scholar]
  43. Mölleken, H.; Theimer, R.R. Survey of minor fatty acids in Cannabis sativa L. fruits of various origins. J. Int. Hemp Assoc. 19974, 13–17. [Google Scholar]
  44. De Meijer, E. The chemical phenotypes (chemotypes) of Cannibis. In Handbook of Cannabis; Pertwee, R.G., Ed.; Oxford University Press: Oxford, UK, 2014; pp. 89–110. [Google Scholar]
  45. Levin, D.A. The role of trichomes in plant defense. Q. Rev. Biol. 197348, 3–15. [Google Scholar] [CrossRef]
  46. Wagner, G.J.; Wang, E.; Shepherd, W. New approaches for studying and exploiting an old proturberance, the plant trichome. Ann. Bot. 200493, 3–11. [Google Scholar] [CrossRef] [PubMed]
  47. Potter, D.J. Cannabis horticulture. In Handbook of Cannabis; Pertwee, R.G., Ed.; Oxford University Press: Oxford, UK, 2014; pp. 65–88. [Google Scholar]
  48. Small, E.; Naraine, S.G.U. Size matters: Evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana). Genet. Resour. Crop Evol. 201663, 349–359. [Google Scholar] [CrossRef]
  49. Grotenhermen, F.; Karus, M. Industrial hemp is not marijuana: comments on the drug potential of fiber CannabisJ. Int. Hemp Assoc. 19985, 96–101. [Google Scholar]
  50. Pertwee, R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br. J. Pharmacol. 2008153, 199–215. [Google Scholar] [CrossRef] [PubMed]
  51. Piomelli, D.; Russo, E.B. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis Cannabinoid Res. 20161.1, 44–46. [Google Scholar] [CrossRef]
  52. Mechoulam, R.; Hanus, L. Cannabidiol: An overview of some chemical and pharmacological aspects. Part I: Chemical aspects. Chem. Phys. Lipids 2002121, 35–43. [Google Scholar] [CrossRef] [PubMed]
  53. Pertwee, R.G. The pharmacology and therapeutic potential of cannabidiol. In Cannabinoids; Di Marzo, V., Ed.; Kluwer Academic/Plenum Publishers: New York, NY, USA, 2004; pp. 32–83. [Google Scholar]
  54. Pertwee, R.G. Pharmacological and therapeutic targets for Δ9-tetrahydrocannabinol and cannabidiol. Euphytica 2004140, 73–82. [Google Scholar] [CrossRef]
  55. Small, E. The Species Problem in Cannabis: Science and Semantics. Volume 2, Semantics; Corpus: Toronto, ON, Canada, 1979. [Google Scholar]
  56. Rock, E.M.; Sticht, M.A.; Parker, L.A. Effect of phytocannabinoids on nausea and vomiting. In Handbook of Cannabis; Pertwee, R.G., Ed.; Oxford University Press: Oxford, UK, 2014; pp. 435–454. [Google Scholar]
  57. Casler, M.D.; Vogel, K.P.; Harrison, M. Switchgrass germplasm resources. Crop Sci. 201555, 2463–2478. [Google Scholar] [CrossRef]
  58. Cherney, J.H.; Cherney, D.J.R.; Akin, D.E.; Axtell, J.D. Potential of brown-midrib, low-lignin mutants for improving forage quality. In Advances in Agronomy; Sparks, D.L., Ed.; Academic Press, Inc.: Orlando, FL, USA, 1991; Chapter 4; Volume 46, pp. 157–198. [Google Scholar]
  59. Amato, J.A. The Great Jerusalem Artichoke Circus: The Buying and Selling of the Rural American Dream; University of Minnesota Press: Minneapolis, MN, USA, 1993. [Google Scholar]
  60. McMinimy, M.A. Biomass Crop Assistance Program (BCAP): Status and Issues; Congressional Research Service Report R41296; CRS: Washington, DC, USA, 2015. [Google Scholar]
  61. Vantreese, V.L. Industrial Hemp: Global Markets and Prices; Department of Agricultural Economics, University of Kentucky: Lexington, KY, USA, 1997. [Google Scholar]
  62. Williams, D.W.; Mundell, R. Agronomic Recommendations for Industrial Hemp Production in Kentucky—2016; University of Kentucky: Lexington, KY, USA, 2016; Available online: (accessed on 14 October 2016).
  63. Meints, J. The hemp plant, humandkind’s savior–50,000 uses and counting. 23 January 2007. Available online: (accessed on 10 November 2016).
  64. Baxter, W.J.; Scheifele, G. Growing Industrial Hemp in Ontario; Factsheet #67; Ontario Ministry of Agriculture, Food and Rural Affairs: Guelph, ON, Canada, 2009. Available online: (accessed on 14 October 2016).
  65. Desanlis, F.; Cerruti, N.; Warner, P. Hemp agronomics and cultivation. In Hemp: Industrial Production and Uses; Bouloc, P., Allegret, S., Arnaud, L., Eds.; CAB International: Wallingford, UK; Boston, MA, USA, 2013; pp. 98–124. [Google Scholar]
  66. Montford, S.; Small, E. Measuring harm and benefit: The biodiversity friendliness of Cannabis sativa L. Glob. Biodivers. 19998, 2–13. [Google Scholar]
  67. Montford, S.; Small, E. A comparison of the biodiversity friendliness of crops with special reference to hemp (Cannabis sativa L.). J. Int. Hemp Assoc. 19996, 53–63. [Google Scholar]
  68. Bouloc, P.; Van Der Werf, H.M.G. The role of hemp in sustainable development. In Hemp: Industrial Production and Uses; Bouloc, P., Allegret, S., Arnaud, L., Eds.; CAB International: Wallingford, UK; Boston, MA, USA, 2013; pp. 278–289. [Google Scholar]
  69. Kerckhoffs, H.; Kavas, Y.; Millner, J.; Anderson, C.; Kawana-Brown, E. Industrial hemp in New Zealand—Potential for cash cropping for a better environment in the Taranaki region. In Proceedings of the 17th Australian Society of Agronomy Conference, Hobart, Australia, 20–24 September 2015.
  70. Riddlestone, S.; Desai, P.; Evans, M.; Skyring, A. Bioregional Fibers, the Potential for a Sustainable Regional Paper and Textile Industry Based on Flax and Hemp; Bioregional Development Group, Sutton Ecology Centre: Carshalton, UK, 1994. [Google Scholar]
  71. Gehl, D. A Summary of Hemp Research in Canada Conducted by the Fibre Division of Agriculture Canada, 1923–1942; Agriculture and Agri-Food Canada: Indian Head, SK, Canada, 1995.
  72. McNulty, S. (Ed.) Report to the Governor’s Hemp and Related Fiber Crops Task Force; Commonwealth of Kentucky: Frankfort, KE, June 1995; Available online: (accessed on 14 October 2016).
  73. Kraenzel, D.G.; Petry, T.; Nelson, B.; Anderson, M.J.; Mathern, D.; Todd, R. Industrial Hemp as an Alternative Crop in North Dakota: A White Paper Study of the Markets, Profitability, Processing, Agronomics and History; Agricultural Economics Report No. 402; The Institute for Natural Resources and Economic Development, North Dakota State University: Fargo, ND, USA, 1998. [Google Scholar]
  74. Marcus, D. Commercial Hemp Cultivation in Canada: An Economic Justification. 1998. Available online: (accessed on 14 October 2016).
  75. Pinfold Consulting. A Maritime Industrial Hemp Product Marketing Study. Prepared for Nova Scotia Agriculture and Marketing (Marketing and Food Industry Development), and New Brunswick Agriculture & Rural Development (Marketing and Business Development). G. Pinfold Consulting Economists Ltd. and J. White, InfoResults Ltd. Irregularly Paginated. 1998. Available online: (accessed on 14 October 2016).
  76. Thompson, E.C.; Berger, M.C.; Allen, S.N. Economic Impact of Industrial Hemp in Kentucky; Center for Business and Economic Research, University of Kentucky: Lexington, KY, USA, 1998. [Google Scholar]
  77. Johnson, P. Industrial hemp: A critical review of claimed potential for Cannabis sativaTappi J. 199982, 77. [Google Scholar]
  78. USDA-ERS. Industrial Hemp in the United States: Status and Market Potential, AGES001E. January 2000; Economic Research Service, U.S. Department of Agriculture. Available online: (accessed on 14 October 2016). [Google Scholar]
  79. Fortenbery, T.R.; Bennett, M. Opportunities for commercial hemp production. Rev. Agric. Econ. 200426, 97–117. [Google Scholar] [CrossRef]
  80. Robbins, L.; Snell, W.; Halich, G.; Maynard, L.; Dillon, C.; Spalding, D. Economic Considerations for Growing Industrial Hemp: Implications for Kentucky’s Farmers and Agricultural Economy; Department of Agricultural Economics, University of Kentucky: Lexington, KY, USA, 2013. [Google Scholar]
  81. Johnson, R. Hemp as an Agricultural Commodity. CRS Report RL32725; Congressional Research Service: Washington, D.C., 26 January 2016; Available online: (accessed on 14 October 2016).
  82. Illinois Industrial Hemp Investigative and Advisory Task Force. Report Submitted to the Illinois Hours of Representatives. 26 January 2000. Available online: (accessed on 14 October 2016).
  83. Bio-Based News. Growing Markets for Hemp Food and Pharmaceuticals—Potential Billion € Markets in Europe. 25 April 2016. Available online: (accessed on 14 October 2016).
  84. Van der Werf, H.M.G. Hemp facts and hemp fiction. J. Int. Hemp Assoc. 19941, 58–59. [Google Scholar]
  85. Meijer, W.J.M.; Vanderwerf, H.M.G.; Mathijssen, E.W.J.M.; Vandenbrink, P.W.M. Constraints to dry-matter production in fiber hemp. Eur. J. Agron. 19954, 109–117. [Google Scholar] [CrossRef]
  86. Biewinga, E.E.; Van der Bijl, G. Sustainability of Energy Crops in Europe. A Methodology Developed and Applied; Report No. 234; Centre for Agriculture and Environment: Utrecht, The Netherlands, 1996. [Google Scholar]
  87. Kuglarz, M.; Alvarado-Morales, M.; Karakashev, D.; Angelidaki, I. Integrated production of cellulosic bioethanol and succinic acid from industrial hemp in a biorefinery concept. Bioresour. Technol. 2016200, 639–647. [Google Scholar] [CrossRef] [PubMed]
  88. Sipos, B.; Kreuger, E.; Svensson, S.E.; Réczey, K.; Björnsson, L.; Guido, Z. Steam pretreatment of dry and ensiled industrial hemp for ethanol production. Biomass Bioenergy 201034, 1721–1731. [Google Scholar] [CrossRef]
  89. González-García, S.; Luo, L.; Moreira, M.T.; Feijoo, G.; Huppes, G. Life cycle assessment of hemp hurds use in second generation ethanol production. Biomass Bioenergy 201236, 268–279. [Google Scholar] [CrossRef]
  90. Prade, T.; Svensson, S.E.; and Mattson, J.E. Energy balances for biogas and solid biofuel production from industrial hemp. Biomass Bioenergy 201240, 36–52. [Google Scholar] [CrossRef]
  91. Ragit, S.S.; Mohapatra, S.K.; Gill, P.; Kundu, K. Brown hemp methyl ester: Transesterification process and evaluation of fuel properties. Biomass Bioenergy 201241, 14–20. [Google Scholar] [CrossRef]
  92. Li, S-Y.; Stuart, J.D.; Li, Y.; Parnas, R.S. The feasibility of converting Cannabis sativa L. oil into biodiesel. Bioresour. Technol. 2010101, 8457–8460. [Google Scholar]
  93. Ragit, S.S.; Mohapatra, S.K.; Kundu, K.; Karmakar, R. Methanolysis and ethanolysis of raw hemp oil: Biodiesel production and fuel characterization. Int. J. Eng. Res. Technol. 2013, 2. [Google Scholar]
  94. Herer, J. Hemp and the Marijuana Conspiracy: The Emperor Wears No Clothes, 10th ed.; Ahha Publishing: Austin, TX, USA, 1996. [Google Scholar]
  95. Survey Research Center. Survey Research Center Data Archive, University of Kentucky. 1995 Kentucky Spring Poll. Available online: (accessed on 14 October 2016).
  96. Chan Halbrendt, C.; Wang, Q.; Mole, M.C. Alternative agricultural strategies in Vermont: The case of industrial hemp. In Proceedings of the Vermont Agricultural Economic Development Conference, South Burlington, VT, USA, 16 December 1996.
  97. Cortilet, A. Industrial Hemp Research. Report to the Minnesota Department of Agriculture. Minnesota Law 2014: HF3172-3 (SF2785); Chapter 312: Article 12; Section 3. 15 January 2015. Available online: (accessed on 14 October 2016).
  98. West, D.P. Hemp and Marijuana: Myths & Realities. North American Industrial Hemp Council, Inc., 1998. Available online: (accessed on 14 October 2016).
  99. Callaway, J. Current status of FINOLA in the EU. Available online: (accessed on 10 November 2016).
  100. NORML and the NORML Foundation. Industrial use of marijuana. Washington DC, USA. Available online: (accessed on 10 November 2016).
  101. Texas hemp Campaign. Austin, TX, USA. Available online: (accessed on 14 October 2016).
  102. North American Industrial Hemp Council. Madison, WI, USA. Available online: (accessed on 11 November 2016).
  103. Hempethics. Oroville, CA, USA. Available online: (accessed on 11 November 2016).
  104. Caulkins, J.P.; Hawken, A.; Kilmer, B.; Kleiman, M.A.R. Marijuana Legalization: What Everyone Needs to Know; Oxford University Press: New York, NY, USA, 2012. [Google Scholar]
  105. Brady, T.C. The argument for the legalization of industrial hemp. San Joaquin Agric. Law Rev. 200313, 85–108. [Google Scholar]
  106. Kolosov, C.A. Evaluating the public interest: Regulation of industrial hemp under the Controlled Substances Act. UCLA Law Rev. 200957, 237–274. [Google Scholar]
  107. Thedinger, S. Prohibition in the United States: International and U.S. regulation and control of industrial hemp. Colo. J. Int. Environ. Law Policy 200617, 419–446. [Google Scholar]
  108. Keller, N.M. The legalization of industrial hemp and what it could mean for Indiana’s biofuel industry. Indiana Int. Comp. Law Rev. 201323, 555–590. [Google Scholar]
  109. Dwyer, S.D. The hemp controversy: Can industrial hemp save Kentucky. Ky. Law J. 199786, 1143–1182. [Google Scholar]
  110. Rogers, V. The future of hemp in Kentucky. Ky. J. Equine Agric. Nat. Resour. Law 20124, 479–500. [Google Scholar]
  111. Shepherd, C.D. Lethal concentration of power: How the D.E.A. acts improperly to prohibit the growth of the industrial hemp. UMKC Law Rev. 199968, 239–262. [Google Scholar]
  112. Duppong, T.A. Industrial Hemp: How the classification of industrial hemp as marijuana under the Controlled Substances Act has caused the dream of growing industrial hemp in North Dakota to go up in smoke. N. D. Law Rev.200985, 403–434. [Google Scholar]
  113. Lash, R. Industrial hemp: The crop for the Seventh Generation. Am. Indian Law Rev. 200227, 313–356. [Google Scholar] [CrossRef]
  114. Moran, C.N. Industrial hemp: Canada exports, United States imports. Fordham Environ. Law Rev. 201526, 383–449. [Google Scholar]
  115. Health Canada, Office of Controlled Substances. Ottawa, Ontario, Canada, 2016. Available online: (accessed on 14 October 2016).
  116. Roth-Li, G. Industrial Hemp (Cannabis sativa)—Economic Viability and Political Concerns; White Paper Prepared for Representative Cynthia Thielen; Hawaiian State Legislature: Honolulu, HI, USA, 1996. Available online: (accessed on 14 October 2016).
  117. MAFES. An Assessment of Industrial Hemp Production in Maine; Maine Agricultural and Forest Experiment Station: Orono, ME, USA, 2016; Available online: (accessed on 14 October 2016).

    This article is originally written by Jerome H. Cherny, School of Integrative Plant Science, Soil and Crop Sciences Section, Cornell University, Ithaca, NY 14853, USA
    Ernest Small, 
    Science and Technology Branch, Agriculture and Agri-Food Canada, Ottawa, ON K1A 0C6, Canada
    Academic Editor: Peter Langridge


CBG is non-psychoactive, which means that it can’t get you high. However, CBG may help to balance the effects of THC and other cannabinoids by promoting synergy. CBG can also directly affect the body in many ways.

Generally speaking, cannabinoids work by interacting with cannabinoid receptors, which are found throughout the human body.
CBG acts on both cannabinoid receptors (CB1 and CB2) as a partial agonist. However, the effect that CBG has on CB1 and CB2 receptors is very weak compared to THC.
CBG can also affect the body by increasing anandamide levels. Anandamide is a naturally-occurring cannabinoid that helps regulate many biological functions, including appetite, sleep and memory. Like THC, anandamide acts on CB1 and CB2 receptors to produce its effects.
CBG also inhibits the uptake of GABA (gamma aminobutyric acid), a brain chemical that regulates the activity of neurons. The effect of CBG on GABA uptake was found to be greater than both THC and CBD in one study.
CBG has been shown to block serotonin receptors as well, which suggests a role for CBG in treating depression.
Since CBG can act on the central nervous system without causing a high, the potential benefits and medical uses of CBG have attracted significant interest.


The medical benefits of CBG are still under investigation, but the list thus far is impressive and growing.
It’s important to note that most of the evidence comes from pre-clinical studies, meaning that the safety and efficacy of CBG has yet to be proven in humans. That being said, studies on CBG have revealed a wide range of possible benefits.
Stimulates bone formation and healing. In a 2007 study, the effects of CBG and other cannabinoids on bone marrow cultures were investigated. The results showed that they could stimulate bone marrow stem cells indirectly through the CB2 receptor. This suggests that CBG and other cannabinoids may help with the healing of bone fractures by promoting new bone growth and formation.
Slows tumor growth. In a 2009 review article, CBD, CBG, and CBC along with other cannabinoids were reported to slow the progression and growth of various tumors and cancer cells. By slowing tumor growth, these cannabinoids could extend the life of people who are battling cancer.
Antifungal and antibacterial treatment. The antifungal and antimicrobial properties of various cannabinoids, including CBG, are currently under investigation. CBG was shown to be highly effective against MRSA in a 2008 study. MRSA (Methicillin-resistant Staphylococcus aureus) is a highly prevalent antibiotic-resistant strain of bacteria.
Relieves pain. CBG and other cannabinoids are known to have analgesic effects in various conditions, including pain caused by multiple sclerosis and cancer. According to a 2008 review article, clinical trials have shown that synthetic cannabinoids are well tolerated and effective, and may have an added analgesic effect when combined with other pharmaceuticals for pain treatment.
Reduces inflammation. Cannabinoids like CBG have the ability to reduce inflammation by targeting specific molecules responsible for inflammation in various disease states, including pain syndromes, cancer, and even inflammatory bowel disease. For example, studies show that CBG can act as a COX-2 inhibitor, similar to widely used pharmaceuticals called non-steroidal anti-inflammatory drugs (NSAIDs).
Overactive bladder treatment. Cannabis and cannabinoid preparations have been used to treat various bladder dysfunctions. In a 2015 study, researchers tested the effects of CBG and other cannabinoids on experimentally-induced bladder contractions. CBG and THCV were found to have the strongest ability for reducing bladder contractions.
Psoriasis and skin treatment. CBG and other cannabinoids could be helpful for treating various skin disorders, due to the presence of cannabinoid receptors in the skin. In a 2007 study, CBG was shown to inhibit keratinocyte proliferation, which suggests a role for CBG in the treatment of psoriasis.
Glaucoma treatment. In a 1990 study, treatment with THC and CBG increased aqueous flow by two to three times in animal models of glaucoma. Increased aqueous flow can help reduce intraocular pressure in cases of glaucoma.
Depression and anxiety treatment.  It is well-known that THC can help patients who suffer from depression and anxiety.  CBG has been found to have similar effects but without causing the high that THC is known for. A 2016 report suggests that non-psychoactive cannabinoids like CBG could be a possible alternative for treating anxiety and depression.
Neuroprotective effects. In a 2015 study on animal models of Huntington’s disease, CBG was found to be “extremely active as a neuroprotectant.” Treatment with CBG improved movement and recovery in mice with Huntington’s and protected neurons from degeneration. CBG also showed possible anti-inflammatory and antioxidant effects. The researchers concluded that CBG should be studied further as a treatment for neurodegenerative disorders.

This article is originally written by Jerome H. Cherny, School of Integrative Plant Science, Soil and Crop Sciences Section, Cornell University, Ithaca, NY 14853, USA
Ernest Small, 
Science and Technology Branch, Agriculture and Agri-Food Canada, Ottawa, ON K1A 0C6, Canada


CBD, or cannabidiol, is quickly changing the debate surrounding the use of marijuana as a medicine.Most people have heard of a chemical called THC, which is the ingredient in marijuana that gets users high. But recently, attention has shifted to another compound in marijuana called CBD — and for good reason.
Because while doctors can’t seem to look past certain side effects of THC, CBD doesn’t appear to present that problem. On the other hand, evidence of CBD’s medical benefits continues to grow.
Here are five facts that you should know about this unique compound:
1. CBD is a key ingredient in cannabis (CBD) is one of over 60 compounds found in cannabis that belong to a class of molecules called cannabinoids. Of these compounds, CBD and THC are usually present in the highest concentrations, and are therefore the most recognized and studied.
CBD and THC levels tend to vary among different plants. Marijuana grown for recreational purposes often contains more THC than CBD.
However, by using selective breeding techniques, cannabis breeders have managed to create varieties with high levels of CBD and next to zero levels of THC. These strains are rare but have become more popular in recent years.

2. CBD is non-psychoactiveUnlike THC, CBD does not cause a high. While this makes CBD a poor choice for recreational users, it gives the chemical a significant advantage as a medicine, since health professionals prefer treatments with minimal side effects.
CBD is non-psychoactive because it does not act on the same pathways as THC. These pathways, called CB1 receptors, are highly concentrated in the brain and are responsible for the mind-altering effects of THC.
A 2011 review published in Current Drug Safety concludes that CBD “does not interfere with several psychomotor and psychological functions.” The authors add that several studies suggest that CBD is “well tolerated and safe” even at high doses.

3. CBD reduces the negative effects of THC & CBD seems to offer natural protection against the marijuana high. Numerous studies suggest that CBD acts to reduce the intoxicating effects of THC, such as memory impairment and paranoia.
CBD also appears to counteract the sleep-inducing effects of THC, which may explain why some strains of cannabis are known to increase alertness.
Both CBD and THC have been found to present no risk of lethal overdose. However, to reduce potential side effects, medical users may be better off using cannabis with higher levels of CBD.

4. CBD is still illegal, Even though CBD shows much promise as a medicine, it remains illegal in many parts of the world. CBD is classified as a Schedule I drug in the United States and a Schedule II drug in Canada.
On Dec. 14 2016, the U.S. Drug Enforcement Agency (DEA) made it clear that any marijuana-based extract is considered a Schedule I drug under federal law, including CBD oil and other types of CBD-rich extracts.
On the other hand, the U.S. Food and Drug Administration recently approved a request to trial a pharmaceutical version of CBD in children with rare forms of epilepsy. The drug is made by GW Pharmaceuticals and is called Epidiolex.
According to the company, the drug consists of “more than 98 percent CBD, trace quantities of some other cannabinoids, and zero THC.” GW Pharmaceuticals makes another cannabis-based drug called Sativex, which has been approved in over 24 countries for treating multiple sclerosis.
A patent awarded to the U.S. Health and Human Services in 2003 (US6630507) also covers the use of CBD as a treatment for various neurodegenerative and inflammatory disorders.


Screening Cut-off: 50 ng/ml
DEA Drug Class: Hallucinogen
Type: Illicit Drug
Trade Names: Dronabinol, Hashish, Marijuana, Marinol, Delta-9-Tetrahydrocannabinol
Street Names: Aunt Mary, Blunt, Blunts, Boom, Bud, Cannabis, Chronic, Doobie, Dope, Gangster, Ganja, Grass, Grifa, Hash, Hash Oil, Hemp, Herb, Hydro, Indo, Joint, Mary Jane, Mj, Mota, Nail, Pot, Reefer, Sinsemilla, Skunk, Smoke, Weed, Yerba

Drug Information

THC (Δ9-tetrahydrocannabinol) is the primary active ingredient in cannabis (Marijuana). When smoked or orally administered, THC produces euphoric effects. Users have impaired short-term memory and slowed learning. They may also experience transient episodes of confusion and anxiety. Long-term, relatively heavy use may be associated with behavioral disorders. The peak effect of marijuana administered by smoking occurs in 20-30 minutes and the duration is 90-120 minutes after one cigarette. Elevated levels of urinary metabolites are found within hours of exposure and remain detectable for 3-10 days after smoking. The main metabolite excreted in the urine is 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (Δ9-THC-COOH).
Drug Enforcement Agency (DEA) Drug Classification and Effects Information
  • Classification/Schedule I: Illicit drugs with no medical use; high potential for abuse
  • Physical Dependency: Unknown
  • Psychological Dependency: Moderate
  • Tolerance: Yes
  • Possible Effects: Euphoria, relaxed inhibitions, increased appetite, disorientation
  • Effects of Overdose: Fatigue, paranoia, possible psychosis
  • Withdrawal Syndrome: Occasional reports of insomnia, hyperactivity, decreased appetite


What Is The Difference Between Tetrahydrocannabinol (THC) And Cannabidiol (CBD)?

The cannabis plant contains dozens of cannabinoids. The most well known cannabinoid for a long time has been tetrahydrocannabinol (THC), but as more scientific research is conducted involving cannabis and its ability to be used as a medicine, more and more people are learning about other cannabinoids, especially cannabidiol (CBD). The last couple of years interest in CBD has grown exponentially, as it’s been featured on numerous television episodes showing how well it works in treating people who suffer from severe epilepsy. One of the most common questions I get asked these days is ‘what is the difference between THC and CBD?’

The most important thing that I try to get people to grasp is that THC will get you high (assuming you consume enough of it) and CBD will not. THC has psychoactive properties that affect your brain and give you a ‘buzz’ while CBD does not. I have talked to many, many people that avoided medical cannabis at all costs simply and only because they didn’t want to be high all the time. Once they understand that there are dozens of cannabinoids, and that they all don’t get you stoned (specifically CBD), they are much more open to the idea of trying medical cannabis.
A brief description of THC is below, via Wikipedia:

Tetrahydrocannabinol (THC), or more precisely its main isomer (−)-trans-Δ9-tetrahydrocannabinol ( (6aR,10aR)-delta-9-tetrahydrocannabinol), is the principal psychoactive constituent (or cannabinoid) of the cannabis plant. First isolated in 1964 by Israeli scientists Raphael Mechoulam and Yechiel Gaoni at the Weizmann Institute of Science[8][9][10] it is a water-clear glassy solid when cold, which becomes viscous and sticky if warmed.


A brief explanation of CBD is below, via Project CBD:
Cannabidiol — CBD— is a cannabis compound that has significant medical benefits, but does not make people feel “stoned” and can actually counteract the psychoactivity of THC. The fact that CBD-rich cannabis doesn’t get one high makes it an appealing treatment option for patients seeking anti-inflammatory, anti-pain, anti-anxiety, anti-psychotic, and/or anti-spasm effects without troubling lethargy or dysphoria.
For a more thorough description, watch the video below, courtesy of SC Labs:


Most people know that THC, or tetrahydrocannabinol, is the chemical compound in cannabis responsible for a euphoric high. But what more is there to know about cannabis’ primary psychoactive component? Whether the question comes as a newbie to the cannabis world or an experienced consumer who would like to know a bit more about the most famous of cannabinoids, THC has likely been synonymous with cannabis in your mind for as long as you’ve known about the plant.


The first step to understanding THC is to understand cannabinoids. Cannabinoids are chemical compounds found in the cannabis plant that interact with receptors in the brain and body to create various effects. There exist dozens, and potentially more than 100, cannabinoids in the cannabis plant, but THC is most widely known among these due to its abundance and psychoactive attributes.
The isolation of THC came from an Israeli chemist by the name of Raphael Mechoulam. In 1964, Mechoulam isolated and synthesized THC from Lebanese hashish, marking the beginning of cannabis research that would lead to the discovery of many other cannabinoids, cannabinoid receptors throughout the body, and “endocannabinoids” – the THC-like compounds our body naturally produces to maintain stability and health.
Why does cannabis produce cannabinoids? Cannabinoids are known as secondary metabolites, which means they are chemicals the plant produces that have no primary role on the plant’s development. However, the leading hypothesis is that secondary metabolites act as an immune system for the plant, fending off predators, parasites, and pests.
Because humans (and many other animals) have receptor systems that THC binds to, we can also reap the benefits of cannabinoids for both health and enjoyment. This system, called the endocannabinoid system (or ECS), is a group of specialized signaling chemicals (think “keys”), their receptors (think “locks”), and the metabolic enzymes that produce and break them down. These endocannabinoid chemical signals act on some of the same brain and immune cell receptors (CB1 and CB2) that plant cannabinoids like cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) act on.


 Simply put, THC works by binding to cannabinoid receptors concentrated in the brain and central nervous system to produce psychoactive effects. But does that mean our bodies evolved for cannabis?
Well, not quite. Before envisioning a symbiotic relationship between cannabis and humans, it’s important to be introduced to “endogenous cannabinoids” such as anandamide and 2AG – the human body’s naturally occurring cannabinoids. You may be familiar with anandamide if you’re, say, a runner and have experienced the wave of euphoria after a successful jog, commonly known as “runner’s high.” The bottom line? Our bodies evolved to interact with natural cannabinoids such as anandamide, but this same system is responsible for the effects experienced from THC and other cannabinoids.


THC has a wide range of short-term effects which may or may not be experienced depending on the individual. For example, while some may find that THC elicits strong feelings of calm and peace, others may notice an increase in their anxiety levels. The difference can be as simple as one’s own body chemistry, but certain strains and varying concentrations of THC can also create different outcomes in how one feels.
If one cannabis strain elicits unpleasant feelings, another may be just the right medley to induce a very enjoyable sensation. Consider consulting a thorough strain database to find what’s right for you, and as always, it’s wise to “start low and go slow” –  consume a little at a time and then wait to see how you feel. Remember, a cannabis high can last for a few hours, but it will wear off.


  • Elation
  • Relaxation
  • Sedation
  • Pain relief
  • Memory impairment
  • Energy
  • Hunger
  • Drowsiness
  • Increased heart rate
  • Dry mouth
  • Red eyes
  • Slowed perception of time
  • Laughter
  • Dizziness
  • “Couch-lock,” or feeling heavy
  • Anxiety/paranoia


There is very little concrete evidence to support theories about the long-term effects of THC. Research is ongoing and inconclusive, and with time, some of the prevailing theories may be confirmed or ruled out entirely. That said, research into the long-term effects of THC currently includes the following potential effects.
Anatomical Brain Changes: In a recent study, researchers found a link between frequent high-THC consumption and anatomical alterations in a region of the brain called the corpus callosum, which connects the two cerebral hemispheres. Using data from participants who self-reported their cannabis use, researchers found that daily consumers of high-potency THC strains showed differences in corpus callosum microstructure compared to occasional consumers and those who had never consumed cannabis. However, the anatomical differences between frequent consumers of high-THC cannabis and the other groups could not be linked with psychosis, which was another key variable that researchers in this study considered. In addition, it’s important to note that due to the self-reported nature of this study, there is no independent verification of the accuracy of these results.
Bronchitis: A result of smoking in general, these symptoms can be thwarted by choosing alternative consumption methods, such as vaporization.
Memory: A study from March 2016 suggested a decrease in verbal cognitive function over an extended period of consistent cannabis consumption. For every five years of cannabis use, participants were found to lose memory of one word from a 15-word list. However, this study had a very small sample size of long-term cannabis users, so it’s difficult to know how conclusive their findings really are. In addition, once again, cannabis use was self-reported, so there’s no independent verification of the accuracy of how frequently subjects consumed cannabis.
Psychosis: Only truly a concern for those predisposed to certain psychotic conditions such as schizophrenia and other such disorders, research has found the onset of symptoms may develop an average of three years earlier with regular cannabis use.
Tolerance: The body naturally builds up a tolerance for THC with extended, long-term use. The downside to this is that increased levels of consumption will be required to achieve the desired effects. A simple solution? Tolerance breaks.
Beyond these studies, there is little known long-term risk to THC/cannabis use. The following are some things you do not have to worry about, based on research.
Cancer: There is no consistent evidence to support an increase in cancer risk (lung or otherwise) with THC consumption. However, smoking should be avoided as inhaling smoke does carry health risks.


THC has many medicinal benefits. There are a variety of conditions for which THC may offers benefits: Cannabis research remains in the early stages, and it is very likely that as this research continues to gain traction and grow with the advancement of legalization, our understanding of how THC and other cannabinoids can be utilized for the treatment of these and other conditions will expand. New research continues to emerge consistently.


The main difference between THC and CBD, both of which are very popular cannabinoids, is in their psychoactive effects. THC elicits strong cerebral euphoria, while CBD lacks psychoactive effects altogether. This basically comes down to the fact that THC activates CB1 receptors in our brain while CBD does not. CBD’s subtle effects are primarily felt in pain, inflammation, and anxiety relief, as well as other medicinal benefits.


There are myriad ways to consume THC, the most common and obvious being smoking. Decarboxylation (which occurs with heating) is the key to enjoying THC, and this holds true whether one intends to smoke it or eat it. In its raw form, cannabis is non-psychoactive, with its primary cannabinoid being THCA. However, by applying heat, either when lighting it in a pipe or cooking it into oil, the THCA is converted to THC, and then the magic can begin.
There are plenty of different ways to enjoy THC. Consider your options and choose the method that is right for you and/or any conditions you may be treating.
With so much to be said about THC, the above information may act as a good jumping off point for the inquiring mind, and in time, as research continues to grow and expand, there will surely be much more to learn and understand.

Cannabidiol CBD

Contrary to popular belief, the marijuana plant is a whole lot more than just a psychoactive drug that”stoners” use to get high.

In raw form, marijuana leaves and buds are actually loaded with a non-psychoactive, antioxidant, anti-inflammatory, and an anti-cancer nutrient compound known as cannabidiol (CBD) that is proving to be a miracle “superfood” capable of preventing and reversing a host of chronic illnesses.

Though you may not have heard much about it, the CBD found in the Cannabis or marijuana plant, which is technically just a herb, is a highly medicinal substance with unique immune-regulating capabilities.

Since the human body already contains a built-in endogenous cannabinoid system, complete with cannabinoid receptors, inputting CBD from marijuana can help normalize the body’s functional systems, including cell communication and proper immune function.

The way CBDs work is that they bridge the gap of neurotransmission in the central nervous system, including in the brain, by providing a two-way system of communication that completes a positive “feedback loop”. As opposed to a one-way transmission, which can promote chronic inflammation of healthy tissue, the unique two-way transmission system engaged by marijuana CBDs mimics the body’s own natural two-way communications system.

One of the best ways to obtain CBDs is to juice raw marijuana leaves and buds. CBD works on receptors and we have endogenous cannabinoids that are very effective at regulating immune functions, nerve functions, bone functions.
The endogenous cannabinoid system acts as a modulator in fine-tuning and if something is deranged biochemically in a person’s body, a phytocannabinoid can bring things back into balance.

While some U.S. states like California and Colorado are beginning to recognize and accept that marijuana has legitimate therapeutic value, the US Federal Government continues to classify marijuana as a Schedule 1 drug with” no currently accepted medical use”.

Cannabidiol CBD is non-psychoactive and can trigger apoptosis in immune cells as well as act as an anti-inflammatory agent.

This opens new avenues with wide-ranging clinical application in the treatment of autoimmune hepatitis as well as other inflammatory disease.

Cannabinoid research has increased tremendously during the last 10 years since the discovery of cannabinoid receptors and the endogenous ligands for these receptors.
The receptors include CB1, predominantly expressed in the brain, and CB2, primarily found on the cells of the immune system. Unlike THC, which exerts its action by binding to the cannabinoid receptors, CB1 and CB2, CBD does not bind to CB1 receptors and hence has no psychotropic activity.

CB2 selective agonists, devoid of psychotropic effect, can trigger apoptosis in immune cells and act as novel anti-inflammatory/immuno-suppressive agents, for instance in treating hepatitis.

CBD is present in most cannabis preparations (hashish, marijuana, ganja) in higher concentrations than THC.
CBD has no psychotropic (cannabimimetic activity) and does not bind either the brain or the peripheral receptors, CB1 and CB2. CBD has, however, been observed to have anti-convulsant effects.

CBD has also been effective in animal models predictive of anti-psychotic activity, and has been found to have anti-psychotic effects in the, case of schizophrenia.


Bio-mass from food crops and their byproducts is used to make Biofuel.
Hemp’s long history in civilization and the multitude of products that can be derived from this single plant has made it one of the most valuable and sustainable plants in the history of mankind.

For the pioneer biofuel industry, hemp provided the biomass that Henry Ford needed for his production of ethanol before prohibition last century. Bast fibre crops include such species as Flax, Kenaf, Sun Hemp and Industrial Hemp. The “hurd” is the inner woody core of the bast fibre plant’s stem. In general bast fibre crops produce the greatest amount of usable bio-mass, over the shortest period, for the least amount of water. 

Bast crops are a highly efficient mop crop and can use most types of waste or even brackish water. Between 1.7 and 1.9 tonnes of carbon dioxide is absorbed from the atmosphere for each tonne of bast crop cellulose produced.
We typically grow 10-14 tonnes of crop straw per hectare. Another 2-3 tonnes of cellulose mass is produced and stored in the root system. Each hectare of hemp can sequester about 22 tonnes of greenhouse gases. Industrial hemp crops are able to sequester more carbon than trees in a short 150 day season cycle and leave arable land available for food and other crops during the remainder of the year.

Pyrolytic conversion Organic plants are converted into pyrolytic fuel using a thermo-chemical process. Using the same technology as fossil fuels, the conversion of plants into renewable energy is the most efficient method of producing charcoal, pyrolytic oil, gas or methanol.

Pyrolysis occurs whenever solid organic material is heated strongly in absence of oxygen, e.g. when frying, roasting, baking, toasting. The process also occurs when burning compact solid fuel, like wood.

An ancient industrial use of anhydrous pyrolysis is the production of charcoal through the pyrolysis of wood. More recently, pyrolysis has been used on a massive scale to turn coal into coke for metallurgy, especially steel making.
Anhydrous pyrolysis can also be used to produce liquid fuel similar to diesel from solid biomass or plastics. Pyrolysis of wood for charcoal was a major industry replaced by coal during the 1800’s Industrial Revolution.

Bio-diesel from hemp seed

Hemp seed oil has been used as lamp oil for thousands of years and has many historical links over many cultures. Bio-diesel is composed of methyl and ethyl esters. Any source of complex fatty acid can be used to create Bio-diesel and glycerin.

Peanut oil, hemp oil, corn oil, and tallow are used as sources for the complex fatty acids used in the separation process. Vegetable oils were used in diesel engines until the 1920’s when an alteration was made to the engine, enabling it to use a residue of petroleum – what is now known as diesel #2. 30% hemp seed oil is usable as a high-grade diesel fuel and that it could also be used as machine lubricant and engine oil.

Bio-diesel remains in the political and economic arena and is playing a part in this process as the awareness of alternative fuel spreads through the consciousness of the general public.


Always use real, unsalted butter. You will need a large pot with a lid, spoon, strainer, cloth, large bowl.
  • Water (Enough to keep the herb floating 50mm above the bottom of the pot).
  • Unsalted butter 500 grams
  • Cannabis 15 to 30 grams with all stalks and seeds removed.
The Cannabis to butter ratio can vary to suit your need. 1:1 weight ratio for weak leaf.
Cannabis strength varies and there is no “standard” so quantities are approximate.
Use your own judgement when measuring based on your knowledge of the Cannabis you’re using.
  • Heat the water on low until it reaches a simmer.
  • Add the butter and allow it to melt.
  • Add the Cannabis.
  • Slowly boil off all the water in the butter.
The secret is to get the mixture up over 150C or 300F degrees.
This converts most of the THC-acid, which doesn’t get you high, into THC which does get you high.

  • Simmer for about four hours.
  • Cover the pot to reduce evaporation.
  • Stir occasionally.
  • Add small amounts of water if the pot starts to dry up.
When done, the mixture will look much like dirty bong water with a thick, glossy layer on top.
  • Line a strainer with cheese cloth.
  • Strain the plant matter and squeeze all the butter into a large bowl.
  • Allow to cool then refrigerate.
A few hours later, the mixture is cool enough that the CannaButter has solidified on the surface.
The THC-infused CannaButter separates from the water as it cools.
Remove the firm CannaButter from the water in the bowl and store it in the fridge or freezer.
Use in any recipe that calls for butter.
Try quarter or half a cookie at first to gauge the effect.

  • 3 1/2 cups flour
  • 1 teaspoon baking powder
  • 1/2 teaspoon salt
  • 1 cup CannaButter, softened
  • 1 1/2 cups sugar
  • 2 eggs 2 teaspoons vanilla
  1. Combine flour baking powder and salt and set aside.
  2. Cream together CannaButter and sugar.
  3. Beat in eggs one at a time and then add vanilla, slowly add flour mixture until well blended.
  4. Cover and refrigerate 2 hours.
  5. Preheat oven to 180C or 350F
  6. Roll out dough onto a lightly floured surface.
  7. Cut into shapes and place on greaseproof paper on a tray
  8. Bake 8-10 minutes or until very lightly browned.
  9. Remove from cookie sheets and cool.
There are many variations to the recipe for CannaButter and cookies.

Healing Oil

Cannabis is a truly gifted medicinal herb that can really heal with minimum side effects.
  • Cannabis Healing Oil
  • Bees wax (If you are allergic to bees try sorbolene instead)
  • Double steamer
  • Amber glass bottle with lid
  • Place the water in the bottom pot and oil and wax in the top pot of the steamer.
  • Measure about 20% wax and 80% oil by volume
  • Heat water (bottom pot) till wax melts, (top pot).
  • Stir in well.
  • Cool a sample to check consistency.
  • Add more wax to make it firmer or oil to make softer.
  • Pour into the bottle and cool.
Therapeutic UseCan be used externally or internally. Yes it has aphrodisiac properties too. Remember this is one of the safest known herbs to humankind.
Confident and complete control of anything from tropical ulcers to pimples, insect bites to burns, chronic nerve, muscle and bone pain,migraine headache, severe back and neck pain, nerve & allergic rashes.
Cannabis is a truly gifted medicinal herb that can really heal with minimum side effects.